Glanbia stock
GL9.IRDUBGlanbia plc, Consumer DefensiveISIN IE0000669501
67Score 67 out of 100, Neutral
Price and trend
56 / 100
Price history
+31% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 1.4% below it.
Since August 2025 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 48).
The price is 20% below its 52-week high. Largest decline in 20 years: 66% (March 2008 to December 2008).
Chart figures for advanced users
- SMA 50$22.55
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$22.46
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)48
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$15.73
- The lowest closing price of the last twelve months.
- Resistance$27.64
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Glanbia plc belongs to the Packaged Foods industry (Ireland) and, with a market value of $5.26B, is number 41 of 75 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $4.11B (up 3.3% year on year) and earnings of $190.77M (up 11.9%).
- MEQIRI Score 67 out of 100 (Neutral): rank 99 of 295 in Consumer Defensive, median 62.
Show more
- The P/E is 22.9 (Packaged Foods median 18.7, own median of recent years 18.3).
- Our model puts fair value at $28.02, with the price 21% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Reliable dividendNo dividend cut for over 26 years.Capital allocation 80
- Share buybacksShare count down 15% since 2020.Capital allocation 80
- Earnings turn into cashFree cash flow 160% of earnings over the last 12 months.Fundamentals 91
Weaknesses
None of our weakness checks flags anything. Crash risk is measured separately.
Its standout strengths are fundamentals and capital allocation.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 68 to 67.
Fundamentals are strong, with stable profits and strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What lowers it
- solid fundamentals
Valuation
Valuation signal
Modestly undervaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $20.01 and expensive above $46.70 (uncertainty high, one part of the fair value is more than twice the other).
The two parts of the fair value come to $38.01 (cash-flow model) and $18.03 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $24.80, at 7.8% it would be $32.86.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (18.7).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Jun 2026, revenue was roughly flat on the twelve months before. Revenue has grown solidly since 2006, at about 4% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 25%, operating 9%, net 5%.
Debt & balance sheet
latest quarterThe balance sheet is solid, with moderate debt and comfortable interest coverage.
Earnings
- Next earnings
- 3 Mar 2027in 111 days
- Last reported
- 6 Aug 2026EPS reported 0.7 (expected 0.61)above expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- 1.45+2.5%
- Revenue
- $3.77B+0.3%
- Earnings per share
- 1.54+2.1%
- Revenue
- $3.95B+0.7%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook raised
Share price after the results: +6.4%2026 guidance raised, with expectations now above the medium-term algorithm: Performance Nutrition growth of 12% to 14%, Health & Nutrition 8% to 10%, and Dairy Nutrition EBITDA of $170 million to $180 million.
“Following a strong first half, we now expect Dairy Nutrition EBITDA to be in a range of $170 million to $180 million for the full year. We also expect profitability growth in the joint venture and now expect profit after tax to be approximately $20 million for the full year.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 6 Aug 2026 (fiscal Q2 2026), read by AI.
What happened at Glanbia
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
295 rated companies in Consumer Defensive
- This company
- 67
- Sector median
- 62
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Packaged Foods
The next larger and next smaller companies by market value
- EmmiEMMN.SW $6.18B69
- Toyo Suisan Kaisha2875.T $6.12B72
- IngredionINGR $5.85B61
- Nissin Foods Holdings2897.T $5.23B57
- AAK AB (publ.)AAK.ST $4.63B61
- Post HoldingsPOST $3.55B60
- SüdzuckerSZU.DE $3.43B43
- FreshpetFRPT $3.17B57
ETFs that hold Glanbia
Held by 29 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares EURO STOXX Small UCITS ETFIQQS | 1.47% | 0.40% | €405.6M |
| UBS MSCI EMU Small Cap UCITS ETF EUR disUEFD | 0.82% | 0.28% | €627.81M |
| iShares STOXX Europe 600 Food & Beverage UCITS ETF (DE)EXH3 | 0.81% | 0.46% | €353.84M |
Show 5 more
| State Street SPDR EURO STOXX Low Volatility UCITS ETF (Acc)ZPRL | 0.75% | 0.30% | €29.81M |
| iShares STOXX Europe Small 200 UCITS ETF (DE)EXSE | 0.57% | 0.20% | €632.25M |
| WisdomTree Eurozone Quality Dividend Growth UCITS ETF EUR AccWTIM | 0.43% | 0.29% | €49.19M |
| WisdomTree Europe Equity UCITS ETF EUR AccWTDF | 0.31% | 0.32% | €131.6M |
| Xtrackers MSCI Europe Small Cap UCITS ETF 1CXXSC | 0.29% | 0.30% | €3.43B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = €0.8987)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral since 7 Nov 2026, previously Strong
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.